Prostate cancer affects approximately 1 in 7 men and is the second most common cause of cancer-related deaths among men in the United States. As the diagnosis and treatment of prostate cancer have advanced, so has the rate of patients choosing active surveillance. When active treatment is appropriate, radical prostatectomy is one of the leading therapeutic options. Robotic assistance helps ensure maximum efficacy and has led to increased utilization.

Michael Whalen, MD discusses robotic treatment for prostate cancer. He highlights advances in surgical technology and how an enhanced understanding of anatomy of the neurovascular bundle can help to afford better outcomes in terms of continents and potency.